Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, et al. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017;102(8):1352-1360.

Begum A, Ewachiw T, Jung C, Huang A, K Norberg J, Marchionni L, et al. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma. PLoS One. 2017;12(7):e0180181.

Giulino-Roth L, van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, et al. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma. Mol Cancer Ther. 2017;16(9):1779-1790.

Mezache L, Magro C, Hofmeister C, Pichiorri F, Sborov D, Nuovo GJ. Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions. Appl Immunohistochem Mol Morphol. 2017;25(2):100-109.

Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, et al. T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4. Am J Clin Pathol. 2017;147(2):188-203.

Scognamiglio T. C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid. Arch Pathol Lab Med. 2017;141(12):1646-1652.

Moschini M, Soria F, Susani M, Korn S, Briganti A, Rouprêt M, et al. Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy. Bladder Cancer. 2017;3(3):161-169.

Nguyen GH, Olson LC, Magro CM. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome. Ann Diagn Pathol. 2017;28:54-59.

Pisapia DJ, Magge R, Ramakrishna R. Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma. Front Neurol. 2017;8:707.

Pizzi M, Inghirami G. Patient-derived tumor xenografts of lymphoproliferative disorders: are they surrogates for the human disease? Curr Opin Hematol. 2017;24(4):384-392.